Document Detail

Comparison of clinical outcome and costs with CC + gonadotropins and gnrha + gonadotropins during Ivf/ICSI cycles.
MedLine Citation:
PMID:  15526974     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To compare clinical outcome and costs of CC + gonadotropins with GnRHa + gonadotropins during IVF/ICSI cycles.
MATERIALS AND METHODS: Clinical outcome and expenses of 382 CC + gonadotropin and 964 GnRHa + gonadotropin cycles were compared. Medication costs were calculated on the basis of the mean number of ampoules and the proportion of various gonadotropins. Costs per clinical pregnancy were calculated on the basis of expenses and clinical pregnancy rates.
RESULTS: Women in the CC + gonadotropin group were younger, and had fewer follicles, oocytes, embryos, and embryos transferred. Clinical pregnancy rates were higher in the GnRHa group (35.9 % vs 26.2%, p < 0.001). More ampoules of gonadotropins were used in the GnRHa group (24.0 +/- 0.3 vs 20.0 +/- 0.5, p < 0.001). Medication costs per cycle were higher in the GnRHa group (US dollars 357 vs 248). Expenses per pregnancy however were lower in the GnRHa group (USdollars 4197 vs 5335 with IVF; USdollars 5590 vs 7244 with ICSI). When different age subgroups with similar baseline characteristics and stimulation parameters were compared, pregnancy rates were significantly higher in the GnRHa groups. Medication cost per cycle was higher in the GnRHa subgroups, and the expense per pregnancy was lower with GnRHa protocol.
CONCLUSIONS: Cost per cycle is higher with GnRHa + gonadotropin. However, because of the better performance of the GnRHa + gonadotropin stimulation, the cumulative costs are reduced by the time a clinical pregnancy is achieved.
Peter Kovacs; Szabolcs Matyas; l Artur Bernard; Steven G Kaali
Related Documents :
6354104 - Ovulation and pregnancy after pulsatile administration of gonadotropin releasing hormone.
1551954 - Comparison of short versus long-term leuprolide acetate--human menopausal gonadotrophin...
19249034 - Beneficial effect of autologous endometrial cell coculture in patients with repeated im...
12470524 - Impact of urinary fsh price: a cost-effectiveness analysis of recombinant and urinary f...
16231324 - Predicting the result of additional second-trimester markers from a woman's first-trime...
22930024 - Maternal obesity in high-risk pregnancies and postpartum infectious complications.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of assisted reproduction and genetics     Volume:  21     ISSN:  1058-0468     ISO Abbreviation:  J. Assist. Reprod. Genet.     Publication Date:  2004 Jun 
Date Detail:
Created Date:  2004-11-05     Completed Date:  2004-12-09     Revised Date:  2013-02-19    
Medline Journal Info:
Nlm Unique ID:  9206495     Medline TA:  J Assist Reprod Genet     Country:  United States    
Other Details:
Languages:  eng     Pagination:  197-202     Citation Subset:  IM    
Kaali Institute IVF Center, 1125 Budapest, Istenhegyi ut 54/a, Hungary.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Costs and Cost Analysis
Embryo Transfer
Fertilization in Vitro / economics*
Follicle Stimulating Hormone / blood
Gonadotropins / economics*,  therapeutic use*
Oocytes / physiology
Pregnancy Outcome
Sperm Injections, Intracytoplasmic / economics*
Reg. No./Substance:
0/Gonadotropins; 9002-68-0/Follicle Stimulating Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Expression of integrin fraction and adhesion molecules on human granulosa cells and its relation wit...
Next Document:  Improved outcome of frozen-thawed blastocyst transfer with Menezo's two-step thawing compared to the...